Published in S Afr Med J on September 01, 2006
The side effects of phototherapy for neonatal jaundice: what do we know? What should we do? Eur J Pediatr (2011) 1.04
Interscapular site for transcutaneous bilirubin measurement in preterm infants: a better and safer screening site. J Perinatol (2014) 0.84
Exchange Transfusion for Neonatal Hyperbilirubinemia in Johannesburg, South Africa, from 2006 to 2011. Int Sch Res Notices (2016) 0.75
Regulatory effect of antibody on the immune response. Adv Immunol (1968) 6.03
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol (1972) 4.94
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Dev (1996) 4.10
The relationship between 'job strain,' workplace diastolic blood pressure, and left ventricular mass index. Results of a case-control study. JAMA (1990) 4.00
Breast-milk substitutes--a South African perspective urgently needed. S Afr Med J (1995) 3.98
Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. Nature (1991) 3.43
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol (1968) 3.38
Thymus-independent B-cell induction and paralysis. Adv Immunol (1975) 3.27
Informal advice- and information-seeking between physicians. J Med Educ (1981) 3.23
Evaluation of a modified self-report measure of social adjustment. Br J Psychiatry (1982) 3.06
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet (1995) 2.43
Risk and severity of motor vehicle crashes in patients with obstructive sleep apnoea/hypopnoea. Thorax (2008) 2.42
Activation of B lymphocytes by locally concentrated concanavalin A. Eur J Immunol (1972) 2.41
Frequency of antigen-sensitive cells to thymus-independent antigens. Cell Immunol (1971) 2.39
Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int (1999) 2.37
A retrospective review of cervical cytology in women developing invasive squamous cell carcinoma. Br J Obstet Gynaecol (1983) 2.31
The management of acute bronchiolitis. Thoracic Society of Australia and New Zealand. J Paediatr Child Health (1993) 2.30
Effects of postnatal depression on infant development. Arch Dis Child (1997) 2.24
The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry (1999) 2.23
Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol (2000) 2.20
Increased incidence of cervical cytological abnormalities in women with genital warts or contact with genital warts: a need for increased vigilance? Genitourin Med (1991) 2.19
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
19S antibody production against soluble lipopolysaccharide antigens by individual lymphoid cells in vitro. Nature (1965) 2.12
Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol Psychiatry (2011) 2.06
Epstein-Barr virus-induced systemic lupus erythematosus. S Afr Med J (1995) 2.06
Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med (1974) 2.04
Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes. Clin Exp Immunol (1969) 2.03
A new venous prosthesis. Surgery (1972) 2.01
Specificiy of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells. Cell Immunol (1972) 1.93
Studies at the cellular level of the 19S immune response. Acta Pathol Microbiol Scand (1966) 1.93
Inclusion of xylan in a medium for the enumeration of total culturable rumen bacteria. Appl Environ Microbiol (1978) 1.91
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med (2001) 1.88
Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans. Scand J Immunol (1974) 1.87
Persistence of immunogenicity of two complex antigens retained in vivo. Immunology (1968) 1.87
Hysterectomy and psychiatric disorder: I. Levels of psychiatric morbidity before and after hysterectomy. Br J Psychiatry (1982) 1.83
Religious coping and depression among elderly, hospitalized medically ill men. Am J Psychiatry (1992) 1.82
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
B lymphocytes can be stimulated by concanavalin A in the presence of humoral factors released by T cells. Eur J Immunol (1972) 1.81
B cell mitogenic properties of thymus-independent antigens. Nat New Biol (1973) 1.80
A randomized controlled trial of the psychosocial impact of providing internet training and access to older adults. Aging Ment Health (2002) 1.79
Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem (1984) 1.77
Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76
Fractures of the spine in diffuse idiopathic skeletal hyperostosis. Clin Orthop Relat Res (1991) 1.76
Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures. J Immunol (1972) 1.73
Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells. Cell Immunol (1970) 1.71
T cell growth factor abrogates concanavalin A-induced suppressor cell function. J Exp Med (1981) 1.68
Incidence of acquired demyelination of the CNS in Canadian children. Neurology (2009) 1.63
In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis. Eur J Immunol (1973) 1.62
Cyclosporin A blocks receptors for HLA-DR antigens on T cells. Nature (1981) 1.61
Purpura fulminans: recognition, diagnosis and management. Arch Dis Child (2011) 1.59
Differentiation of B cells: sequential appearance of responsiveness to polyclonal activators. Scand J Immunol (1974) 1.57
Weight change in Alzheimer's disease. J Am Geriatr Soc (1996) 1.57
Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien) (1998) 1.56
The effector cell in antibody-induced cell mediated immunity. Transplant Rev (1973) 1.56
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
Syphilis in the 'unbooked' pregnant woman. S Afr Med J (1992) 1.52
Requirement for adherent cells in the primary and secondary immune response in vitro. Eur J Immunol (1972) 1.51
Immunological unresponsiveness to thymus-independent antigens: two fundamentally different genetic mechanisms of B-cell unresponsiveness to dextran. J Exp Med (1977) 1.50
Job, psychological factors and coronary heart disease. Swedish prospective findings and US prevalence findings using a new occupational inference method. Adv Cardiol (1982) 1.49
Lipopolysaccharides can convert heterologous red cells into thymus-independent antigens. Cell Immunol (1972) 1.48
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Effect of B-cell mitogens on lymphocyte subpopulations possesing C'3 and Fc receptors. J Exp Med (1974) 1.46
Suppressive effect of graft versus host reactions on the immune response to heterologous red cells. Immunology (1971) 1.45
Induction of DNA synthesis in human lymphocytes: interaction between non-specific mitogens and antigens. Immunology (1970) 1.45
Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes. Eur J Immunol (1990) 1.44
Prolonged survival of H-2 incompatible skin allografts on F1 animals treated with parental lymphoid cells. Immunology (1969) 1.44
Neuro-ophthalmological assessment of vision before and after radiation therapy alone for pituitary macroadenomas. J Neurosurg (1990) 1.43
Regulation of cellular antibody synthesis. Cellular 7S production and longevity of 7S antigen-sensitive cells in the absence of antibody feedback. J Exp Med (1968) 1.42
HTLV-1 infection and tropical spastic paraparesis in Esmeraldas Province of Ecuador. Trans R Soc Trop Med Hyg (1995) 1.42
Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells. J Exp Med (1973) 1.39
Lymphocytic responses to streptococcal antigens in glomerulonephritic patients. Science (1970) 1.39
Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection. Int J Tuberc Lung Dis (2004) 1.39
Massive lymphocytic infiltration of uterine leiomyomas associated with GnRH agonist treatment. Histopathology (1998) 1.38
The management of acute laryngo-tracheo-bronchitis (croup): a consensus view. J Paediatr Child Health (1992) 1.38
The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol (2004) 1.37
Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology (1999) 1.37
One non-specific signal triggers b lymphocytes. Transplant Rev (1975) 1.36
Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect Dis (2004) 1.35
The cognitive development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry (1996) 1.35
Effects of psychological stress on human semen quality. J Androl (1997) 1.34
Characterization of self-reactive B cells by polyclonal B-cell activators. J Exp Med (1977) 1.34
Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia. Hum Mol Genet (1996) 1.33
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
In vitro induction of specific immune responses in the absence of serum: requirement for nonspecific T or B cell mitogens. Eur J Immunol (1973) 1.32
The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc (1998) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
The reliability, validity, and stability of a measure of physical activity in the elderly. Arch Phys Med Rehabil (1996) 1.30
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol (2009) 1.30
Role of C'3 and Fc receptors in B-lymphocyte activation. J Exp Med (1975) 1.30
The nephrotic syndrome in children. S Afr Med J (1976) 1.28
Follicular cervicitis--colposcopic appearances and association with Chlamydia trachomatis. Br J Obstet Gynaecol (1981) 1.28
The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology (1996) 1.28
Induction of autoantibodies to red blood cells by polyclonal B-cell activators. Nature (1976) 1.26
Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut (2006) 1.26
Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity. Cell Immunol (1975) 1.26